Belly fat more than doubles the risk for liver damage from alcohol, study finds
The risk of serious liver damage from alcohol is more than twice as high for people with belly fat and diabetes, a new study found.
Experimental transplants with organs from gene-edited pigs see major steps forward
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...
hemophilianewstoday2d
‘Problem joints’ linked to worse clinical outcomes in hemophilia A
Hemophilia A patients with self-described problem joints were found to have worse clinical outcomes, with more pain, in a new study.
Endovascular Today3d
Arsenal’s EMBO-02 Study of NeoCast for cSDH Treatment Enrolls Initial Cohort
Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
Northwestern Medicine is a global leader in clinical trial research, including spineCLARITY is a randomized study designed to demonstrate ...
ICON Public (NASDAQ:ICLR) Price Target Cut to $265.00 by Analysts at JPMorgan Chase & Co.
ICON Public (NASDAQ:ICLR – Get Free Report) had its price target reduced by equities researchers at JPMorgan Chase & Co. from $280.00 to $265.00 in a research note issued on Monday,Benzinga reports.
sicklecellanemianews5d
First patient enrolled in Phase 1 trial testing fostamatinib for SCD
The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle cell disease.
Multiple Sclerosis News Today9d
MS patients at higher risk of mental illness with pregnancy: Study
Women with MS face a significantly higher risk of mental health problems during and after pregnancy than those without MS, a ...
Pulmonaryhypertensionnews.com9d
Early Winrevair trial end to allow all patients to start active treatment
Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...
Yahoo Finance9d
Here’s Why Baron Small Cap Fund is Holding ICON Public Limited Company (ICLR)
Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ:ICLR) is a clinical research organization. The ...
hemophilianewstoday9d
Blood stem-cell gene therapy leads to stable FVIII levels in small study
Gene therapy using modified blood stem cells helped five adults with severe hemophilia A reach therapeutic levels of clotting ...
Contract Pharma9d
ICON Expands Portfolio of AI Tools
ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...